ArticleEuropean journal of nutrition2025
Dietary advanced glycation end products intake, genetic predisposition and risk of coronary heart disease: a prospective study.
Article in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveDietary advanced glycation end products (AGEs) intake may be associated with coronary heart disease (CHD) risk. We aimed to investigate the association between dietary AGEs intake and CHD risk and to further investigate whether this association could be influenced by genetic risk.
methodsData from UK Biobank were used. Dietary AGEs intake, including Nε-(carboxymethyl) lysine (CML), Nε-(1-Carboxyethyl)-L-lysine (CEL), and Nd-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) were calculated by coupling the consumption of food items from 24-hour dietary recall with the dietary AGEs database. Baseline dietary information was first collected through Oxford WebQ 24 h food recall between April 2009 and September 2010. From February 2011 to June 2012, the Oxford WebQ survey was conducted online in four rounds. The association between dietary AGEs and CHD risk was estimated using multivariable-adjusted Cox proportional risk models. The association between dietary AGEs intake and genetic risk with CHD risk was further explored via the multiplicative interaction analyses.
resultsDuring a median follow-up of 12.2 years, 4,348 participants developed CHD. In the fully adjusted model, a higher intake of dietary AGEs, CML and MG-H1 (highest tertile vs. lowest tertile) was associated with a higher risk of CHD [HR, (95% CI):1.12 (1.03,1.23), 1.15 (1.05,1.26) and 1.10 (1.00,1.20), respectively (all P trend < 0.05)]. Among participants with intermediate to high genetic risk, HRs (95% CI) were 1.63 (1.39, 1.91) and 2.45 (2.10, 2.85) for AGEs, 1.67 (1.42, 1.97) and 2.60 (2.23, 3.02) for CML, 1.48 (1.26 1.74) and 2.34 (2.01, 2.72) for CEL, and 1.64 (1.40, 1.92) and 2.31 (1.99, 2.69) for MG-H1, respectively.
conclusionsHigher intakes of dietary AGEs, CML and MG-H1 were associated with an increased risk of coronary heart disease, and there was an interaction between dietary AGEs intake and genetic predisposition on the risk of CHD.
Indexed as
Identifiers
40063212What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.